It is unknown whether KCNQ1 affects the insulin signaling pathway, and whether IR is the underlying mechanism through which KCNQ1 rs2237892 polymorphism influences repaglinide response in patients with T2DM is also unclear. Here, INS is linked to type 2 diabetes mellitus.